Gastric bypass puts type 2 diabetes into remission

Original title: Effects of Ingestion Routes on Hormonal and Metabolic Profiles in Gastric-Bypassed Humans. Reference: Andreas Lindqvist, Peter Spégel, Mikael Ekelund, Hindrik Mulder, Leif Groop, Jan Hedenbro and Nils Wierup. . JCEM, 2013 DOI: 10.1210/jc.2012-3996.

A team of researchers at Lund University has explained why gastric bypass often sends diabetes to fast remission, which could be a step further towards finding a treatment with the same effect. 85% of patients with diabetes type 2 undergoing gastric bypass recover within a few days and show normal levels of blood sugar -long before they lose any weight. Until now, this phenomenon had not been explained. 

“Most previous studies have analyzed samples taken from patients before and after a gastric bypass, but there is a risk that the results are misleading. They may not be attributable to the operation itself, but rather to factors such as weight loss and reduced food intake”, says Nils Wierup of the Lund University Diabetes Centre in Sweden. In a gastric bypass, food bypasses most of the stomach and duodenum. Only a small part of the upper stomach is connected directly to the small intestine. In some cases, the surgeon will insert a catheter into the part of the stomach that no longer has contact with food as a precautionary measure. This was what gave researchers the opportunity to study the exact difference in food intake before and after the procedure.

Participants were given a certain amount of a nutritional drink and blood samples were obtained before, during and, at brief intervals, after ingestion. The next step was to inject the same volume of nutritious mix through the catheter over the same length of time as it had taken the patient to drink it and the same samples were taken. This mix was then received where it would have been before gastric bypass. 

The comparison revealed a major difference. “When the patient drank the solution, insulin blood levels rose almost five times as much as when it was injected into the closed off stomach. Intestinal hormones, which play a significant role in controlling blood sugar levels, rose sharply, as did certain amino acids. There was also a major impact on blood lipids, with the levels roughly halved”, says Nils Wierup, observing: “We believe these changes are part of the answer to why gastric bypass cures type 2 diabetes. We have looked at just a few intestinal hormones. There may be a hundred or more involved in the body’s complex sugar metabolism.” Jan Hedenbro, one of the surgeons in the study, adds: “If we can identify the mechanism behind this, it will open the way for both more individually tailored operations and, in the long run, the possibility of achieving the same results with pills rather than with surgery.” 

Source: Medcenter.com,the leading portal in Latin America

SOLACI.ORG

More articles by this author

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

How real are the adverse effects of statins? Evidence from randomized clinical trials

The safety of statins continues to be a subject of debate, partly due to the extensive list of adverse effects included in prescribing information,...

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...